2 ms·
That's what scares me about the parents the article describes. They are exactly the sort of people who would gladly help dismantle RCTs and try to return drug a
by gwern 11y ago
That's what scares me about the parents the article describes. They are exactly the sort of people who would gladly help dismantle RCTs and try to return drug and medical treatment development to a pre-scientific process. The usage of RCTs is already fragile and threatened - I remember during the Ebola outbreak, there was a ton of pressure to use limited supplies of Zmapp on patients as fast as possible and the suggestions to make the most of the opportunity by allocating scarce doses via lottery were, as far as I know, ignored. That in a situation where it was vital to know as soon as possible whether we had a useful Ebola treatment or not in case it went pandemic!
- JoshTriplett 11y agoIf you're evaluating something for use to keep healthy people healthy, then sure, you want to know they'll still be healthy after 10 years and not afflicted by some terrible long-term side effect. The potential downside of taking it may outweigh the downside of not taking it. On the other hand, if you're evaluating something to keep people from dying, then "not dead" is sufficient in the short-term while continuing to watch for long-term effects. The downside of taking it cannot possibly outweigh the downside of not taking it. (Assuming some reasonable baseline expectation that it treats the condition it intends to treat.)